Healthcare provider reinforces commitment to patient safety and robust governance on World Patient Safety Day

Tuesday 17 September marks the World Health Organisation’s fifth annual World Patient Safety Day, focusing on ‘Improving diagnosis for patient safety’.

Celebrating World Patient Safety Day, Xyla showcases its dedication to high standards of patient care and governance through innovative practices and strategic initiatives.

Xyla, the UK’s first fully integrated healthcare solution, is supporting World Patient Safety Day by championing patient safety through its quality and clinical governance and continued investment in improving patient diagnosis.

Patients receiving care from the NHS, or any health care provider should be treated in a safe environment and safeguarded from avoidable harm.

In a recent Net Promoter Score (NPS) survey 94.45% of respondents agree that delivering safe care is a top priority for Xyla.

Xyla offers a variety of diagnostic tests and services tailored to meet the needs of each community. These tests include 12-lead ECGs, ambulatory blood pressure monitoring, transthoracic echocardiograms and spirometry.

These community-based diagnostics services are patient-centered with timely results delivered by a team of skilled clinicians, analysts and consultants.

Jo Mundy, Diagnostics Director for Xyla said: “Quality, governance and safety are at the heart of the Xyla values and provide us with a framework through which continuous improvements to our services can be focused and measured.

“We are dedicated to providing a seamless and efficient diagnostic experience for patients and healthcare providers alike. Being able to offer a comprehensive range of services is the key to ensuring that every step of the diagnostic pathway is handled with precision and care, from booking patient appointments to delivering detailed analysis and expert consultation.

“We are very proud of our patient safety and innovation in diagnostics, this has been recognised with our recent British Society of Echocardiology Echo Quality Framework Accreditation and our CQC rating of good.”

A recent report from NHS England revealed that just over 2.5 million diagnostic tests were undertaken in July 2024. This is an increase of more than 250,000 from July 2023. This increase in tests and reduction in the number of patients waiting six weeks or more for diagnostics tests is a testament to the added value that independent healthcare providers like Xyla have to the NHS.

Jo added: “Receiving such positive feedback in our NPS survey from NHS partners that they trust Xyla to provide a high quality, safe and reliable service for patients contributes to the achievement of our overall mission, to be the most valued and preferred insourcing provider to the NHS.”

Karen Matthews-Shard, Global Clinical Director, Acacium Group commented, “As a nurse who’s worked on the frontline, I’ve seen first-hand how a quick and accurate diagnosis saves lives. Effective diagnostic services – both in acute and community settings – play a key role in ensuring patient safety and protecting the sustainability of the healthcare system.”

To find out more information about Xyla’s governance framework, patient safety initiatives or how to enhance your diagnostic capabilities visit https://xylaservices.com/professionals/our-services/clinical-care/diagnostic-services/ or contact clinicalcare@xylaservices.com.

For more information contact:

Sophie Saunders | PLMR Genesis | sophie.saunders@genesispr.co.uk  | 01473 326348 or

Alex Mace | PLMR Genesis | alex.mace@genesispr.co.uk | 01473 326432

Links

https://www.england.nhs.uk/statistics/wp-content/uploads/sites/2/2024/09/DWTA-Report-July-2024_3N1L7.pdf